Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience

Background and objectives: Information on the performance of ixekizumab (IXE) in patients with psoriatic arthritis (PsA) in clinical practice is scarce. We aimed to analyze the retention rate and safety of IXE in patients with PsA in routine clinical practice. Methods: A retrospective longitudinal o...

Descripción completa

Detalles Bibliográficos
Autores principales: Braña, Ignacio, Pardo, Estefanía, Burger, Stefanie, González del Pozo, Pablo, Alperi, Mercedes, Queiro, Rubén
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861177/
https://www.ncbi.nlm.nih.gov/pubmed/36675395
http://dx.doi.org/10.3390/jcm12020467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861177/
https://www.ncbi.nlm.nih.gov/pubmed/36675395
http://dx.doi.org/10.3390/jcm12020467

Ejemplares similares